Search Results

Displaying Results 101-125 of 20091 "'R'"

Feb 24, 2026, 16:05 ET Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance

disease focus that supports durable growth and long-term value creation for patients and shareholders.""Jazz had a transformative year across our R&D pipeline, led by the HERIZON-GEA-01 data, which we believe firmly positions zanidatamab as the HER2-targeted agent of choice, with the potential to

More news about: Jazz Pharmaceuticals plc


Feb 24, 2026, 16:05 ET Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance

disease focus that supports durable growth and long-term value creation for patients and shareholders.""Jazz had a transformative year across our R&D pipeline, led by the HERIZON-GEA-01 data, which we believe firmly positions zanidatamab as the HER2-targeted agent of choice, with the potential to

More news about: Jazz Pharmaceuticals plc


Feb 24, 2026, 16:01 ET Axon reports Q4 2025 revenue of $797 million, up 39% year over year

Award, primarily within SG&A and R&D. These performance-based incentive programs are tied to stock price, operational, and time-based requirements, and include seven substantially equal tranches.2026 capital expenditure plans include long-term R&D investment projects, continued capacity

More news about: Axon


Feb 24, 2026, 13:54 ET DDB Capital 52-Acre Residential Community Receives City of Cullman, Alabama Approval

Huntsville employment centers, with everyday services, Cullman Regional Medical Center, and strong local schools nearbyZoning Designation: R-3, approved with conditions through a coordinated planning process with the City of Cullman, aligning infrastructure, phasing, and design standards to

More news about: DDB Capital


Feb 24, 2026, 13:40 ET Cinema Lenses Market to Reach USD 2,288.4 Million by 2032 as High-Resolution Content Demand Surges - Credence Research Inc.

rise of mirrorless and hybrid cinematography is encouraging more versatile lens systems that work across different mounts and formats. Continuous R&D in autofocus, metadata, and sensor-optimized optics remains a key way to compete in both professional and independent segments.Key Player

More news about: Credence Research Inc.


Feb 24, 2026, 12:00 ET New Linux Foundation Report Shows Active Open Source Contribution Delivers 2-5x ROI, While Passive Consumption Increases Costly Technical Debt

help organizations enhance their agility, technical capabilities, and long-term competitiveness."– Hirofumi Inoue, President of Advanced R&D and Engineering Company, Toyota Motor CorporationAbout Linux Foundation ResearchFounded in 2021, Linux Foundation Research

More news about: The Linux Foundation


Feb 24, 2026, 11:25 ET MIĘDZYNARODOWA GRUPA INWESTORÓW W AKTYWA GÓRNICZE W TULKUBASHU i KYZYLTASHU WYDAJE OŚWIADCZENIE

LONDYN, 24 lutego 2026 r. /PRNewswire/ -- grupa międzynarodowych inwestorów w Kirgistanie („Grupa"), która zainwestowała w aktywa górnicze w Tulkubashu i Kyzyltashu za pośrednictwem Chaarat Gold Holdings Limited („Chaarat")

More news about: Group of Chaarat Gold Holdings Limited Investors


Feb 24, 2026, 11:00 ET New Research Shows AI Systems That Shape Public Discourse Face Growing Risk of Political Manipulation

Innovating for the Public Good: R&D for Democracy (IFPG) today released original research revealing that the largest single source of AI Large Language Model (LLM) training data

More news about: Innovating for the Public Good


Feb 24, 2026, 10:49 ET Consegna Pharma Highlights Innovative Modeling and Simulation Strategy as FDA Concurs with Regulatory Pathway for CP217 to Prevent Fentanyl Epidemic Deaths

renarcotization.This work was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number 2R43DA059056. The content of this press release is solely the responsibility of the company and does not necessarily represent the official views of the National

More news about: Consegna Pharma Inc.


Feb 24, 2026, 10:20 ET Ski-Doo Racers Conquer World's Toughest Race the 2026 Iron Dog

family.Together, these athletes demonstrated what's possible when world-class riders meet world-class machines. These racers use the MXZ X-RS 600R E-TEC – the same exact snowmobile anyone can ride, not a limited edition or specialty race snowmobile some competitors use.The Ski-Doo team can't

More news about: BRP Inc.


Feb 24, 2026, 10:20 ET Ski-Doo Racers Conquer World's Toughest Race the 2026 Iron Dog

family.Together, these athletes demonstrated what's possible when world-class riders meet world-class machines. These racers use the MXZ X-RS 600R E-TEC – the same exact snowmobile anyone can ride, not a limited edition or specialty race snowmobile some competitors use.The Ski-Doo team can't

More news about: BRP Inc.


Feb 24, 2026, 10:15 ET Road Safety Market to Reach USD 11.71 Billion by 2032 at 12.4% CAGR, Driven by Intelligent Traffic Safety Solutions, Says Maximize Market Research

mobility across U.S. cities.On March 05, 2025, IDEMIA Public Security expanded a strategic partnership with Tahakom to localize assembly, R&D, and AI innovation for safer roads under Saudi Vision 2030, boosting biometric traffic enforcement adoption.On October 20, 2025, IDEMIA Public

More news about: Maximize Market Research Pvt. Ltd.


Feb 24, 2026, 10:05 ET Hyundai Wins Big with Families: Four Models Honored with 2026 Parents Best Family Cars Awards

headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, several cutting-edge R&D facilities and more than 855 independent dealers. These operations are part of Hyundai Motor Group, which is

More news about: Hyundai Motor America


Feb 24, 2026, 10:02 ET Neurent Medical Announces Publication of Positive Randomized Controlled Trial Results for the NEUROMARK® System

www.neuromark.com                            PAM339r01 Feb 2026

More news about: Neurent Medical


Feb 24, 2026, 10:01 ET Probiotic Ingredients Market to Reach USD 14.7 Billion by 2036 as Clinically Validated Strains Gain Ground in Food, Beverage, and Pharma Applications

players, including developments in animal health and localized R&D infrastructure. For example, the report highlights strategic moves by major participants such as Novonesis (through post-merger positioning) and Kerry Group's expanded R&D and applications presence in Southeast Asia.Competition

More news about: Future Market Insights


Feb 24, 2026, 10:01 ET Surgical Equipment Market to Reach USD 27.40 Billion by 2032, Shows New Maximize Market Research Analysis

Dominate and Disrupt the MarketThe global Surgical Equipment Market is highly competitive and dominated by key players investing heavily in R&D and product innovation:B. Braun SE: Germany-based leader in surgical instruments and disposables.Medtronic plc: Global

More news about: Maximize Market Research Pvt. Ltd.


Feb 24, 2026, 10:00 ET BioNJ Releases Its White Paper "Life Sciences in New Jersey: Prescription for Sustained Leadership"

and Entrepreneurship.Increase investment in Commission on Science, Innovation, and Technology (CSIT) programs, including Catalyst R&D vouchers, R&D seed grants, and Small Business Innovation Research (SBIR) assistance, which together have delivered a 15-times return on investment. Sustain

More news about: BioNJ


Feb 24, 2026, 10:00 ET DAVID DELANEY, MD, NAMED PRESIDENT OF DRUG KNOWLEDGE PROVIDER FDB (FIRST DATABANK)

of drug knowledge that helps healthcare professionals make precise medication decisions. The announcement was made by Hearst President and CEO Steven R. Swartz and Hearst Health President Gregory Dorn, MD. Delaney brings more than two decades of experience, including serving as a critical care physician

More news about: Hearst


Feb 24, 2026, 10:00 ET LARGEST-EVER STUDY OF CARDIAC SCREENING IN YOUNG PEOPLE SHOWS THAT HEART CHECKS IDENTIFY RISK & 'HIDDEN' CONDITIONS - AND SAVE LIVES

and not sustainableFor  more information about CRY please visit www.c-r-y.org.uk   or to book a screening near you, go to www.testmyheart.org.uk  

More news about: Cardiac Risk in the Young


Feb 24, 2026, 09:47 ET /C O R R E C T I O N -- Theranica/

More news about: Theranica


Feb 24, 2026, 09:35 ET Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug

More news about: Market News Updates


Feb 24, 2026, 09:15 ET ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer

The company holds significant intellectual property in inorganic polymer microspheres and proprietary administration systems and operates its own R&D and manufacturing facilities. Eye90 microspheres® is investigational and not approved for commercial use outside of authorized clinical trials.

More news about: ABK Biomedical Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.